E Ringwald, D Hirt, R Markstein, J M Vigouret. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/therapeutic useBromocriptine/therapeutic useDouble-Blind MethodDrug Therapy, CombinationHumansParkinson Disease/drug therapyParkinson Disease/metabolismReceptors, Dopamine/drug effectsReceptors, Dopamine/metabolism
Substances: See more » Antiparkinson AgentsReceptors, DopamineBromocriptine
Year: 1982 PMID: 7063089
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214